Skip to main content
Clinical Trials/JPRN-jRCTs061180103
JPRN-jRCTs061180103
Recruiting
Phase 4

Evaluation of Coronary Artery disease using Dynamic CT perfusion Imaging compared with Ammonia PET for Quantitative assessment (E-CARDIAQ) - E-CARDIAQ

Yamaguchi Osamu0 sites80 target enrollmentMarch 28, 2019

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Yamaguchi Osamu
Enrollment
80
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 28, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Yamaguchi Osamu

Eligibility Criteria

Inclusion Criteria

  • 1\. patients with diagnosed or suspected coronary artery disease
  • 2\. patients who undergo cardiac CT and ammonia\-PET

Exclusion Criteria

  • 1\. clinically unstable patients (acute myocardial infarction, unstable angina, malignant arrhythmia, symptomatic heart failure: NYHA \>class 2, aortic stenosis: \>moderate)
  • 2\. known prior myocardial infarction
  • 3\. known anaphylactic reaction to iodinated contrast
  • 4\. bronchial asthma or uncontrolled hyperthyroidism
  • 5\. chronic kidney disease (Cre \> 1\.5 mg/dl) or hemodialysis
  • 6\. patients with chronic atrial fibrillation
  • 7\. patients with atrial\-ventricular block (2 or 3 degree), sick sinus syndrome
  • 8\. pacemaker or internal defibrillator lead implantation
  • 9\. pregnancy or lactation
  • 10\. previous coronary intervention (within 6 months)

Outcomes

Primary Outcomes

Not specified

Similar Trials